These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 833874)

  • 1. Alteration of cell-surface antigenicity of the mouse plasmacytoma. II. Lack of correlation between synthesis of myeloma protein and alteration of surface antigen.
    Ohno S; Natsu-ume-Sakai S; Migita S
    J Natl Cancer Inst; 1977 Feb; 58(2):229-37. PubMed ID: 833874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of cell-surface antigenicity of the mouse plasmacytoma. I. Immunologic characterization of surface antigens masked during successive transplantations.
    Ono S; Natsu-ume S; Migita S
    J Natl Cancer Inst; 1975 Sep; 55(3):569-77. PubMed ID: 51090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new T cell neoplasm expressing surface anti-DNP activity, developed from the thymus of mice bearing MOPC-315 plasma cell tumors.
    Lahat N; Moroz C
    Adv Exp Med Biol; 1976; 66():477-81. PubMed ID: 1083649
    [No Abstract]   [Full Text] [Related]  

  • 4. Ligand-induced redistribution and augmentation of surface-bound myeloma protein on MOPC 315 plasmacytoma cells.
    Hannestad K; Gaudernack G
    Scand J Immunol; 1977; 6(1-2):59-76. PubMed ID: 403594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor immunity to murine plasma cell tumors. III. Detection of common and unique tumor-associated antigens on BALB/c, C3H, and NZB plasmacytomas by in vivo and in vitro induction of tumor-immune responses.
    Burton RC; Warner NL
    J Natl Cancer Inst; 1977 Mar; 58(3):701-9. PubMed ID: 300112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor immunity induced by preimmunization with BALB/c mouse myeloma protein.
    Freedman PM; Autry JR; Tokuda S; Williams RC
    J Natl Cancer Inst; 1976 Apr; 56(4):735-40. PubMed ID: 56452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular J chain in mouse plasmacytomas secreting IgA, IgM and IgG.
    Kaji H; Parkhouse RM
    Nature; 1974 May; 249(452):45-7. PubMed ID: 4208428
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma-cell and tumor-associated membrane antigens of mouse plasmacytoma MOPC-315 and MOPC-460.
    Comoglio PM; Forni G
    Int J Cancer; 1973 Nov; 12(3):613-25. PubMed ID: 4134007
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of plasmacytomas on serum immunoglobulin levels of BALB/c mice.
    Fenton MR; Havas HF
    J Immunol; 1975 Feb; 114(2 pt 2):793-801. PubMed ID: 1089719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and properties of an antiplasma cell serum directed against a defined plasmacytoma cell population.
    Proctor ML; Herscowitz HB
    J Immunol; 1975 Dec; 115(6):1642-9. PubMed ID: 1184969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of plasmocellular tumours on the humoral immune response in mice (author's transl)].
    Seematter R; Jaquet H
    Ann Immunol (Paris); 1976; 127(1):11-24. PubMed ID: 952495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and viral antigens of BALB-c myeloma.
    Krueger RG; Williams WH; Miller GC
    J Natl Cancer Inst; 1974 Apr; 52(4):1203-10. PubMed ID: 4133200
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors.
    Röllinghoff M; Rouse BT; Warner NL
    J Natl Cancer Inst; 1973 Jan; 50(1):159-72. PubMed ID: 4571237
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of antibody production in plasmacytoma cells by antigen.
    Abbas AK; Klaus GG
    Eur J Immunol; 1977 Oct; 7(10):667-74. PubMed ID: 73462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
    Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
    J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The plasma cell differentiation antigen PC.1 is absent in CH3/Tif and present in C3H/HeJ.
    Gaudernack G; Hannestad K
    Scand J Immunol; 1979; 9(4):373-9. PubMed ID: 87010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface immunoglobulins of lymphocytes in plasmacytoma. V. The effect of RNA-rich extract from mouse plasmacytoma MOPC 104E on the immune response.
    Bhoopalam N; Chen Y; Yakulis V; Heller P
    Clin Exp Immunol; 1976 May; 24(2):357-67. PubMed ID: 1277583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type C virus and immunoglobulin A production by murine myeloma MOPC-315: two independent activities.
    Gazit A; Yaniv A; Halperin D; Ben-Efraim S
    Infect Immun; 1979 Aug; 25(2):569-73. PubMed ID: 226480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Origin of effector and rosette-forming cells in transplantation immunity in mice].
    Brondz BD; Kotomina IF
    Biull Eksp Biol Med; 1973 Sep; 76(9):69-72. PubMed ID: 4130411
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell-surface major glycoprotein of BALB/c mouse plasmacytoma 58-8 cells.
    Tokuyama H; Migita S
    J Natl Cancer Inst; 1978 Jul; 61(1):203-8. PubMed ID: 276626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.